A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis
- PMID: 23486420
- PMCID: PMC3647749
- DOI: 10.1128/CVI.00601-12
A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis
Abstract
The leptospiral immunoglobulin-like (Lig) proteins LigA and LigB possess immunoglobulin-like domains with 90-amino-acid repeats and are adhesion molecules involved in pathogenicity. They are conserved in pathogenic Leptospira spp. and thus are of interest for use as serodiagnostic antigens and in recombinant vaccine formulations. The N-terminal amino acid sequences of the LigA and LigB proteins are identical, but the C-terminal sequences vary. In this study, we evaluated the protective potential of five truncated forms of LigA and LigB proteins from Leptospira interrogans serovar Canicola as DNA vaccines using the pTARGET mammalian expression vector. Hamsters immunized with the DNA vaccines were subjected to a heterologous challenge with L. interrogans serovar Copenhageni strain Spool via the intraperitoneal route. Immunization with a DNA vaccine encoding LigBrep resulted in the survival of 5/8 (62.5%) hamsters against lethal infection (P < 0.05). None of the control hamsters or animals immunized with the other vaccine preparations survived. The vaccine induced an IgG antibody response and, additionally, conferred sterilizing immunity in 80% of the surviving animals. Our results indicate that the LigBrep DNA vaccine is a promising candidate for inclusion in a protective leptospiral vaccine.
Figures
Similar articles
-
Leptospiral Immunoglobulin-Like Domain Proteins: Roles in Virulence and Immunity.Front Immunol. 2021 Jan 8;11:579907. doi: 10.3389/fimmu.2020.579907. eCollection 2020. Front Immunol. 2021. PMID: 33488581 Free PMC article. Review.
-
DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis.Mem Inst Oswaldo Cruz. 2015 Dec;110(8):989-95. doi: 10.1590/0074-02760150222. Epub 2015 Dec 11. Mem Inst Oswaldo Cruz. 2015. PMID: 26676320 Free PMC article.
-
A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans.PLoS Negl Trop Dis. 2011 Dec;5(12):e1422. doi: 10.1371/journal.pntd.0001422. Epub 2011 Dec 13. PLoS Negl Trop Dis. 2011. PMID: 22180800 Free PMC article.
-
Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis.PLoS One. 2017 Jul 13;12(7):e0180004. doi: 10.1371/journal.pone.0180004. eCollection 2017. PLoS One. 2017. PMID: 28704385 Free PMC article.
-
Advances & challenges in leptospiral vaccine development.Indian J Med Res. 2018 Jan;147(1):15-22. doi: 10.4103/ijmr.IJMR_1022_16. Indian J Med Res. 2018. PMID: 29749356 Free PMC article. Review.
Cited by
-
Challenges and Strategies for Developing Recombinant Vaccines against Leptospirosis: Role of Expression Platforms and Adjuvants in Achieving Protective Efficacy.Pathogens. 2023 May 31;12(6):787. doi: 10.3390/pathogens12060787. Pathogens. 2023. PMID: 37375478 Free PMC article. Review.
-
LigA formulated in AS04 or Montanide ISA720VG induced superior immune response compared to alum, which correlated to protective efficacy in a hamster model of leptospirosis.Front Immunol. 2022 Oct 10;13:985802. doi: 10.3389/fimmu.2022.985802. eCollection 2022. Front Immunol. 2022. PMID: 36300125 Free PMC article.
-
Revisiting the Development of Vaccines Against Pathogenic Leptospira: Innovative Approaches, Present Challenges, and Future Perspectives.Front Immunol. 2022 Jan 3;12:760291. doi: 10.3389/fimmu.2021.760291. eCollection 2021. Front Immunol. 2022. PMID: 35046936 Free PMC article. Review.
-
Leptospiral Immunoglobulin-Like Domain Proteins: Roles in Virulence and Immunity.Front Immunol. 2021 Jan 8;11:579907. doi: 10.3389/fimmu.2020.579907. eCollection 2020. Front Immunol. 2021. PMID: 33488581 Free PMC article. Review.
-
A Comparison of Intramuscular and Subcutaneous Administration of LigA Subunit Vaccine Adjuvanted with Neutral Liposomal Formulation Containing Monophosphoryl Lipid A and QS21.Vaccines (Basel). 2020 Sep 1;8(3):494. doi: 10.3390/vaccines8030494. Vaccines (Basel). 2020. PMID: 32882903 Free PMC article.
References
-
- Faine SB, Adler B, Bolin C, Perolat P. 1999. Leptospira and leptospirosis, 2nd ed MediSci, Melbourne, Australia
-
- Reis RB, Ribeiro GS, Felzemburgh RD, Santana FS, Mohr S, Melendez AX, Queiroz A, Santos AC, Ravines RR, Tassinari WS, Carvalho MS, Reis MG, Ko AI. 2008. Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Negl. Trop. Dis. 2:e228 doi:10.1371/journal.pntd.0000228 - DOI - PMC - PubMed
-
- Hartskeerl RA. 2006. Leptospirosis: current status and future trends. Indian J. Med. Microbiol. 24:309. - PubMed
-
- McBride AJ, Athanazio DA, Reis MG, Ko AI. 2005. Leptospirosis. Curr. Opin. Infect. Dis. 18:376–386 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
